Parschauer Karah Herdman (CIK 1677455) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-20). Recent activity: Buy RARE (28,895 shares), Sell RARE (6,018 shares), Sell RARE (3,508 shares), Buy RARE (11,137 shares), Sell RARE (8,135 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Buy | 28,895 | $0 |
| 2026-03-10 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 6,018 | $128,785 |
| 2026-03-10 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 3,508 | $79,526 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Buy | 11,137 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 8,135 | $185,478 |
| 2026-02-19 | Evolus, Inc. (EOLS) | Director | Buy | 45,559 | $0 |
| 2025-09-12 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 2,450 | $76,366 |
| 2025-03-14 | Evolus, Inc. (EOLS) | Director | Sell | 12,888 | $167,415 |
| 2025-03-11 | Evolus, Inc. (EOLS) | Director | Buy | 7,364 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Buy | 18,443 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 12,846 | $540,817 |
| 2025-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 2,230 | $95,734 |
| 2025-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Sell | 760 | $32,490 |
| 2025-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Legal Officer | Buy | 14,494 | $0 |
Source: SEC Form 4 filings · as of 2026-04-20